Cargando…
Notes from the Field: Impact of a Mass Drug Administration Campaign Using a Novel Three-Drug Regimen on Lymphatic Filariasis Antigenemia — American Samoa, 2019
Autores principales: | Hast, Marisa A., Tufa, Aifili, Brant, Tara A., Suiaunoa-Scanlan, Lynette, Camacho, Janet, Vaifanua-Leo, June, Robinson, Keri, Dodd, Emily, Sili, Ben, Lees, Loretta S., Won, Kimberly Y., Utu, Fara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269605/ https://www.ncbi.nlm.nih.gov/pubmed/32463808 http://dx.doi.org/10.15585/mmwr.mm6921a3 |
Ejemplares similares
-
The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific
por: Rainima-Qaniuci, Merelesita, et al.
Publicado: (2022) -
Triple-Drug Treatment Is Effective for Lymphatic Filariasis Microfilaria Clearance in Samoa
por: Graves, Patricia M., et al.
Publicado: (2021) -
Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa
por: Won, Kimberly Y., et al.
Publicado: (2018) -
Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration
por: Lau, Colleen L., et al.
Publicado: (2017) -
Seroprevalence and Spatial Epidemiology of Lymphatic Filariasis in American Samoa after Successful Mass Drug Administration
por: Lau, Colleen L., et al.
Publicado: (2014)